Opinion
Experts warn of mass closure of 6,500 pharma MSMEs as revised Schedule M triggers existential crisis
Peethaambaran Kunnathoor, Chennai Friday, January 23, 2026, 08:00 Hrs [IST] ...
Nadda has directed India's drug regulator and the Department of Pharmaceuticals (DoP) to devise a workable solution to ...
New Delhi: With thousands of small drug manufacturers struggling to meet tougher quality norms, the government is weighing a year's extension to the deadline for complying with the revised good ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results